O13. Subtype-specific KRAS mutations in advanced lung adenocarcinoma

BACKGROUND: So far there is no strong evidence for the predictive effects of KRAS mutations on the clinical outcome of platinum-based chemotherapy in advanced lung adenocarcinoma. However, most of the studies did not take into account the subtype-specific mutations in the KRAS gene. METHODS: For thi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Lohinai, Zoltan, Cserepes, Mihaly, Ostoros, Gyula, Moldvay, Judit, Ghanim, Bahil, Laszlo, Viktoria, Hoda, Mir Alireza, Klepetko, Walter, Hegedus, Balazs, Dome, Balazs
Formato: Artigo
Idioma:Inglês
Publicado em: Pioneer Bioscience Publishing Company 2014
Assuntos:
CELCC 2014 Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367747/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados